Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development

Published:2017-08-24 Issue:10 Volume:26 Page:1103-1114
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Li Huiling¹,Chintalapudi Sumana R.²³,Jablonski Monica M.²³⁴

Affiliation:

1. Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, China

2. Department of Ophthalmology, The Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN, USA

3. Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN, USA

4. Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, TN, USA

Funder

Research to Prevent Blindness

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1369042

Reference97 articles.

1. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain An add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community

2. Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .

3. Prevalence of Early and Late Age-Related Macular Degeneration in India: The INDEYE Study

4. Prevalence and Risk Factors for Age-Related Macular Degeneration in Indians: A Comparative Study in Singapore and India

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging treatments for geographic atrophy and the impact on clinical management of age-related macular degeneration;Clinical and Experimental Optometry;2024-06-04

2. Current Advancements in Mouse Models of Retinal Disease;Retinal Degenerative Diseases XIX;2023

3. Optical Coherence Tomography Measurements of the Retinal Pigment Epithelium to Bruch Membrane Thickness Around Geographic Atrophy Correlate With Growth;American Journal of Ophthalmology;2022-04

4. Automatic geographic atrophy segmentation using optical attenuation in OCT scans with deep learning;Biomedical Optics Express;2022-02-07

5. Interlink between Inflammation and Oxidative Stress in Age-Related Macular Degeneration: Role of Complement Factor H;Biomedicines;2021-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3